Physician profile
John A Walker
NPI 1477536324
$7,131.12
in general payments reported to CMS, 2019-2025
43 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,347 · 2020: $1,108 · 2021: $1,092 · 2022: $1,091 · 2023: $1,328 · 2024: $949 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,056.21 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $770.25 | 2019-2024 | Ozempic, Rybelsus |
| Amgen INC. | $758.03 | 2019-2024 | Prolia, Evenity, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $564.08 | 2019-2024 | Trintellix |
| Lilly USA, LLC | $550.51 | 2019-2024 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $487.33 | 2019-2025 | Breztri, Fasenra, Farxiga |
| Abbvie INC. | $358.12 | 2021-2025 | Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $303.02 | 2022-2024 | |
| Amarin Pharma, INC. | $216.61 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $200.40 | 2020-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $199.11 | 2020-2025 | Xifaxan |
| Pfizer INC. | $174.51 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $152.42 | 2019-2023 | Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.75 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $111.35 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.